Intestinal Epithelial-Specific mTORC1 Activation Enhances Intestinal Adaptation After Small Bowel Resection

Autor: Bola Aladegbami, Brad W. Warner, Jun Guo, Lauren Barron, Raphael C. Sun, Christopher R. Erwin
Rok vydání: 2016
Předmět:
0301 basic medicine
WT
wild type

Pathology
medicine.medical_specialty
Enterocyte
SBR
small bowel resection

Crypt
p-HH3
phosphorylated histone H3

Enteroendocrine cell
mTOR
mammalian target of rapamycin

Biology
digestive system
03 medical and health sciences
PCR
polymerase chain reaction

medicine
lcsh:RC799-869
mTORC
mammalian target of rapamycin complex

PI3K/AKT/mTOR pathway
Original Research
EGF
epidermal growth factor

Goblet cell
Hepatology
S6K
S6 kinase

i-TSC-/-
intestinal epithelial cell–specific tuberous sclerosis complex 1 null mice

Gastroenterology
Intestinal epithelium
Small intestine
TSC1
Raptor
MMP
matrix metalloproteinase

030104 developmental biology
medicine.anatomical_structure
Differentiation
Paneth cell
Cancer research
lcsh:Diseases of the digestive system. Gastroenterology
biological phenomena
cell phenomena
and immunity

TSC
tuberous sclerosis complex

IHC
immunohistochemistry

TAM
tamoxifen
Zdroj: Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 3, Iss 2, Pp 231-244 (2017)
ISSN: 2352-345X
Popis: Background & Aims Intestinal adaptation is a compensatory response to the massive loss of small intestine after surgical resection. We investigated the role of intestinal epithelial cell–specific mammalian target of rapamycin complex 1 (i-mTORC1) in intestinal adaptation after massive small bowel resection (SBR). Methods We performed 50% proximal SBR on mice to study adaptation. To manipulate i-mTORC1 activity, Villin-CreER transgenic mice were crossed with tuberous sclerosis complex (TSC)1flox/flox or Raptorflox/flox mice to inducibly activate or inactivate i-mTORC1 activity with tamoxifen. Western blot was used to confirm the activity of mTORC1. Crypt depth and villus height were measured to score adaptation. Immunohistochemistry was used to investigate differentiation and rates of crypt proliferation. Results After SBR, mice treated with systemic rapamycin showed diminished structural adaptation, blunted crypt cell proliferation, and significant body weight loss. Activating i-mTORC1 via TSC1 deletion induced larger hyperproliferative crypts and disorganized Paneth cells without a significant change in villus height. After SBR, ablating TSC1 in intestinal epithelium induced a robust villus growth with much stronger crypt cell proliferation, but similar body weight recovery. Acute inactivation of i-mTORC1 through deletion of Raptor did not change crypt cell proliferation or mucosa structure, but significantly reduced lysozyme/matrix metalloproteinase-7–positive Paneth cell and goblet cell numbers, with increased enteroendocrine cells. Surprisingly, ablation of intestinal epithelial cell–specific Raptor after SBR did not affect adaptation or crypt proliferation, but dramatically reduced body weight recovery after surgery. Conclusions Systemic, but not intestinal-specific, mTORC1 is important for normal adaptation responses to SBR. Although not required, forced enterocyte mTORC1 signaling after resection causes an enhanced adaptive response.
Graphical Abstract
Databáze: OpenAIRE